From: Potential therapeutic effects of milk-derived exosomes on intestinal diseases
Exosomal sources | Intestinal disease model | Mechanisms | Effect factors | Ref. |
---|---|---|---|---|
Cow milk | DSS-induced UC Mice | Alleviates colitis by regulating the intestinal immune homeostasis via inhibiting NLRP3 and TLR4-NF-κB signaling pathways, restoring the α-diversity of the gut microbiota effectively and Treg/Th17 cell balance. | IL-1β, TNF-α, IL-6, IL-2, and IL-22↓; IL-17 A, L-23R, MPO↓; TLR4, Myd88, iNOS, COX2, p-IκBα, p65↓; ASC, NLRP3, and pro-caspase-1↓; IL-10↑; Akkermansia↑ | [136] |
Cow milk | DSS-induced UC Mice | Modulates the inflammatory response through the interplay between the NFκB and A20, and restore a normal gut microbiota profile. | TNFAIP3, Zo-1↑; NFκB, COX2, and miR-125b↓; pro-inflammatory cytokines↓; anti-inflammatory cytokines↑ | [137] |
Cow and human milk | DSS-induced UC Mice | Attenuates the severity of colitis and reduce colon shortening, reduce the expression of pro-inflammatory cytokine. | TNF-α, IL-6, DNMT1/3↓; TGF-β, miR-320/375, and Let-7↑ | [138] |
Cow milk | DSS-induced UC Mice | Alleviates the severity of acute colitis, reduce the expression of pro-inflammatory cytokines, chemokine ligands and chemokine receptors. | CXCL2/3/5, CCL3/4/11↓; PTGS2, IL-1a, IL-1β, IL-33, IL-6 and IL-17 A↓ | [139] |
Cow milk | DSS-induced UC Mice | Attenuates colitis through optimizing gut microbiota abundance and by regulating the expression of the intestinal genes. | IL-6 and TNF-α↓; Dubosiella, Bifidobacterium, UCG-007, Lachnoclostridium, Lachnospiraceae↑; butyrate and acetate↑ | [140] |
Cow milk | DSS-induced UC Mice | Regulates the concentrations of lipids and amino acids in both fecal samples and colonic tissues, recover the metabolic abnormalities caused by inflammation. | Acetate, butyrate, L-arginine↑; C13:0, C15:1, C20:1, C20:2, C20:5, C22:6↓; L-valine, L-serine and L-glutamate↓ | [141] |
Goat milk | LPS-induced IPEC-J2 cells | Increases the antimicrobial peptides, defensins and toll like receptors, induce the preferential expression of the anti-inflammatory, improve intestinal homeostasis. | IL18, IL12p40, MMP9, NOS2↓; MUC2, EBI3, IL-6, IL-8↑ | [142] |
Human breast milk | LPS-induced NEC mice (intestinal epithelial cells, IEC-6 cells) | Protects against NEC and attenuate TLR4 signaling via EGF/EGFR activation, inhibit enterocyte apoptosis and restore enterocyte proliferation | TLR4, NF-κB, IL-6, IL-1β, GSK3β, iNOS↓; EGFR, PCNA↑ | [150] |
Human breast milk | hypoxia and gavage-induced NEC rat and human normal intestinal epithelial cell line (FHC) | Protects against NEC by promoting intestinal cell proliferation and migration | Ileum injury area↓; villous integrity, proliferation and migration↑ | [152] |
Human breast milk | H2O2-induced NEC (intestinal stem cells, ISCs) | Increases ISC viability, protect ISCs from oxidative stress injury via the Wnt/β-catenin signaling pathway | Axin2, c-Myc, and Cyclin D1↑ | [153] |
Human breast milk | LPS-induced NEC rat (intestinal epithelial cells, IEC-6 cells) | Decreases the incidence and severity of experimental NEC, increase IEC proliferation and decrease apoptosis, protect IEC from injury in vitro | Cell proliferation rate↑; Late apoptotic cells↓; intestinal damage↓; NEC incidence↓ | [154] |
Human breast milk | H2O2-induced NEC (intestinal epithelial cells, IECs) | Increases IEC viability, protects IECs from oxidative stress and cell toxicity induced by H2O2 | cell viability↑ | [155] |
Human breast milk | hypoxia and gavage-induced NEC rat | reduce ischemic necrosis and epithelial damage, increase the number of BrdU-positive cells in the intestinal mucosa, decrease the severities of NEC | intestine length, number of BrdU-positive cells↑; NEC score↓ | [95] |
Human breast milk | LPS-induced NEC mice and human normal intestinal epithelial cell line (FHC) | Enhances epithelial cell proliferation and migration, and ameliorate the severity of LPS-induced NEC via ERK/MAPK pathway | gut damage and necrosis↓; NEC score↓; proliferation and migration↑; p-ERK↓ | [156] |
Human breast milk | Hypoxia, LPS-induced NEC mouse and intestinal epithelial cells (IEC) | Attenuates NEC damage by reducing the intestinal epithelial injury and inflammation, restoring the intestinal mucous production, and increasing goblet cells | IL-6↓; injury condition↓; injury score↓; MPO activity, MUC2↓; goblet cells↑ | [103] |
Human breast milk | LPS-induced NEC mice (Caco-2 and NCM460 cell lines) | Prevents NEC by reducing inflammation and injury in the intestinal epithelium as well as restores the intestinal tight-junction proteins | ZO-1, Claudin 1, and OCLN↑ | [157] |
Human breast milk | LPS-induced NEC mice (intestinal epithelial IEC6 cells) | Exerts significant protective effect on NEC mice, including inhibiting inflammation and cell apoptosis, and improving intercellular tight junctions | miR-148a-3p, SIRT1↑; p53, NF-κB↓ | [94] |
Human breast milk | asphyxia and cold stress-induced NEC mice and LPS-induced intestinal epithelial IEC-6 and IEC-18 Cell Lines | Attenuates the severity of experimental NEC and intestinal damage through reducing NEC score and ileal inflammation, restoring the number of damaged ileal crypts | Lgr5, MBP↑; IL-6, Iba1↓; NEC score↓; ileum crypts number↑; cell migration rate↑ | [96] |
Human breast milk | LPS-induced NEC C57BL/6 mice | Attenuates NEC-induced epithelial injury by reducing inflammation through inhibiting TNFα and TLR4 expression, and stimulating intestinal regeneration | TNF-α, TLR4, Ki67 and Lgr5↓; | [158] |
Porcine milk | DON-induced NEC mice and porcine jejunum intestinal enterocytes IPEC-J2 cells | Protects the intestine against DON-induced damage by promoting cell proliferation and TJs and by inhibiting cell apoptosis | β-catenin, cyclin D1, p-Akt↑; ZO-1, OCLN, and CLDN1↑; p53, p21, Caspase 3, Caspase 9, Fas, and SERPINE1↓; miR-181a, miR-365-5p, miR-30c, and miR-769-3p↑ | [112] |
Porcine milk | LPS-induced NEC mice | Protects against the LPS-induced intestine epithelial cell injury by inhibiting cell apoptosis and inflammation through the p53 and TLR4/NF-κB pathway via the action of exosome miRNAs | IL-1β, IL-6, and TNF-α↓; p53, FAS, and Caspase-3↓; TLR4, Myd88, p-IκBα and p-NF-κB↓; miR-4334, miR-219, and miR-338↑ | [113] |
Bovine milk | LPS, hypoxia, and hyperosmolar formula feeding induced NEC mouse and human colonic LS174T cells | Prevents NEC-induced mouse intestinal injury by increasing goblet cell production and ER function | MUC2, TFF3, and GRP94↑; mucin production and goblets cell↑; MPO↓ | [159] |
Rat milk | Intestinal epithelial cells (IEC-18) | Prevents NEC by promoting IEC viability and proliferation, and stimulating intestinal stem cell activity | PCNA, Lgr5, and cell viability↑ | [119] |
Bovine milk | Human colon cancer (HCT116) cell lines | Inhibits colon cancer cell growth and survival, and anti-inflammatory activity, providing an effective alternative for oral delivery | cell growth and survival↓ | [170] |
Human breast milk | Colon epithelial cell line (CRL 1831) | Reduces risk of colon cancer by elevating the expression of miR-148a and decreasing DNA methyltransferase1 | miRNA-148a↑; DNMT1↓ | [171] |
Human breast milk | Colonic epithelial cells (CCD 841) and colonic tumor cells (LS123) | Alter the miRNA expression profile of the colon epithelial cells and promote the proliferation of healthy colon epithelial cells without affecting the growth of the colon cancer cells | miR-148a↑; collagen-type I, PTEN, and DNMT↓ | [173] |
Bovine milk | Colorectal cancer cells (LIM1215, SW620) | Attenuates tumor burden through decreasing the number of colonies and increasing cell death in the colorectal cancer cells | Number of colonies↓; percentage of cell death↑; tumor volume↓ | [117] |
Goat milk | Mouse colon cancer cell line (MC38) | Enhances the antitumor effect of the photothermal therapy and reduce the inflammatory response after treatment | Ki67, TNF-α, IL-6, and IL-1β↓; tumor weights↓; CD3+CD4+ and CD3+CD8+↑; | [174] |
Buffalo milk | Colorectal cancer cells HCT116, and HT-29 | High expression of miR-27b induce higher cytotoxic effects, CRC cell apoptosis, ROS and lysosome accumulation via PERK/IRE1/XBP1 and CHOP protein modulation | ROS, PERK, IRE1, XBP1, ATF6, CHOP, Bax/Bcl-2, p-ERK/ERK, procaspase-12, p-p38/p38, and p-JNK/JNK↑; apoptosis, lysosome, ER-tracker↑ | [175] |
Human breast milk | Intestinal IR injury rats | Protects the intestine against damage from IR injury by decreasing the intestinal inflammation and enhancing epithelial proliferation | TNFα↓; Ki67↑; Intestinal IR injury score↓ | [190] |